Investor Info

Designated person for Grievance redressal : Shri Dhirendra Dubey
Email : dkdkilpest@yahoo.co.in


Nodal Officer for the purpose of IEPF:
Nikhil Kuber Dubey
Director
Ph: 0755-2586536/2586537
Email: cs@kilpest.com, kilpest@bsnl.in,info@kilpest.com



DISCLOSURE UNDER REGULATION 46(2) OF SEBI LODR REGULATIONS, 2015


KILPEST is one of India’s leading Agri-based companies, established in the year 1972. Shri R.K. Dubey is the founder of this company. It was the only pesticide formulating company in the entire region of Madhya Pradesh in 1970s. The company has now grown over the years and is leading today in Central India and manufactures about 50 pesticide products, microfertilizers, biofertilizers and biopesticides. The company is enlisted with Bombay Stock Exchange Ltd. since 1996.

Kilpest has representation in India in the field of agriculture business comprising crop protection, public health products and bio-products and is reputed reliable supplier to various Govt. organizations, such as Directorate General of Supplies & Transport, New Delhi, NAVY, Vishakapatnam/Mumbai, Food Corporation of India Raipur/Bhopal/Lucknow/Mumbai/Jaipur, NTPC, Bilaspur, Directorate of Health Service, M.P/Maharashtra/AP, Directorate of General Of Health Organization, Gujarat/U.P, Directorate General of Health services, MOH&FW (NVBDCP), Govt. of India, M/s Hindustan Latex Ltd, Noida, Director of Agriculture and Horticulture, M.P./Trivandrum, Central/Western Railway, Mumbai, Northern Railway, New Delhi etc. the company has nationwide distribution network of over 2000 dealers.

It possess well equipped R&D laboratory duly approved and recognized by DSIR, Ministry of Science and Technology, Government of India. Advanced instrumentation facility supported by equally competent team of scientists and technicians lay down a strong R&D foundation. Clean and hygienic environment ensure the consistency and reliability of results. Laboratory studies are planned, performed, monitored, recorded, applied in small scale field and then tabulated.

The products are manufactured to high International specifications with stringent quality control from raw material procurement to finished goods dispatch. The company’s manufacturing process is complimented with the technical expertise and it has attained high standard suited to customer needs on 23-7-2002. Kilpest has received accreditation of International standard ISO 9001-2000 certified company. The companyhas diversified manufacturing in the field of micronutrients, bioproducts and plant growth regulators etc. The company is also exporting its products to Bangladesh and Afghanistan.


NAME CHANGE INTIMATION

Kilpest Annual report 2023
Financial Results 2023-2024
Secretarial Audit Report for the year ended 31-03-2023
Proceedings of AGM dt 22-09-23
Re-appointmrnt of Director in AGM dt 22-09-23
Annual Report-2023-Final
Unclaimed Unpaid dividend as on AGM dt 22-09-2022
Draft Form_MGT_7 2023
kilpest-declaration-under-rule-37bc-2023
kilpest-form-10F-2023
Kilpest-form-15G-2023
Kilpest-form-15H-2023
Applicable-Tax-Deduction-at-Source-(TDS)-provisions-under-the-Income
checklist-receipt-of-remittance-foreign-party
KILPEST-RESIDENT-TAX-DECLARATION
Self-Declaration-for-availment-of-Treaty-Benefit-
corporate declaration-.pdf
Joint-Shareholders-declaration
KILPEST-NON-RESIDENT-TAX-DECLARATION



Model Tripartite Agreement
Model Tripartite Agreement

Statement of deviation/variatio

Statement of deviation and variation dt 08-04-2024
Statement of Deviation dt 06-04-2023
Statement of deviation and variation dt 29-07-2019
Statement of deviation and variation dt 20-04-2022

INVESTORS GRIEVANCE
Investor Grievance
Directors Kilpest
KMP Kilpest
Newspaper Publication (2023-24)

Newspaper publication FR quarter 31-12-2023
Newspaper publication of Notice of BM quarter FR 31-12-2023
Newspaper Publication of 51st AGM dt 22-09-2023
Newspaper Publication of sending of Notice of 51st AGM dt 22-09-2023
Newspaper publication of Notice of BM quarter FR 30-09-2023
Newspaper publication of FR quarter FR 30-09-2023
Newspaper publication of Notice of BM quarter FR 30-06-2023
Newspaper publication of FR quarter FR 30-06-2023

Newspaper Publication (2022-23)

Newsaper publication of Audited FR 31-03-2023
Newspaper Publication of Audited FR dt 31-03-2023
Newspaper Publication of hearing of petition Newspaper Publication of court convened meeting Newspaper Publication of Unaudited FR dt 31-12-2022 Newspaper Publication of Unaudited FR dt 30-09-2022 Newspaper Publication of Unaudited FR dt 30-06-2022 Newspaper Publication of sending of Notice of 50th AGM dt 22-09-2022 Newspaper Publication of 50th AGM dt 22-09-2022
Newspaper Publication (2021-22)

Newspaper Publication of Unadited FR dt 31-12-2021
Newspaper Publication of Unadited FR dt 30-09-2021
Newspaper Publication of Unadited FR dt 30-06-2021
Newspaper Publication of Audited FR dt 31-03-2022
Newspaper Publication of 49th AGM dt 22-09-2021

Newspaper Publication (2020-21)

Newspaper Publication of Audited FR dt 31-03-2021
Newspaper Publication of 48th AGM dt 22-09-2020

Audited Financials of Subsidiary Companies
Audited Financial Statements FY 2017-18
Audited Financial Statements FY 2018-19
Audited Financial Statements FY 2019-20
Audited Financial Statements FY 2020-21
Audited Financial Statements FY 2021-22

Criteria for making payment to Non-Executive Director

Schedule of Analysts or Institutional investors Meet.
Schedule of Analyst meet-intimation dt 20-06-2023
Schedule of Analyst meet-Addendum to Intimation dt 01-09-2023
Schedule of Analyst meet-outcome dt 05-09-2023
Schedule of Analyst meet-intimation dt 01-09-2023
Schedule of Analyst meet-outcome dt 21-06-2023
Intimation of Investor Meet dt August 10, 2020
Intimation of Investor Meet dt July 14, 2020
Intimation of Investor Meet dt March 5, 2021
Intimation of Investor Meet dt September 26, 2020


Credit Rating




Annual returns

Form_MGT_7 2021
Form_MGT-7 2020
Form_MGT-7 2018
Form_MGT_7 2019
Form_MGT_7 2022
Form_MGT_7 2017
Annual Return MGT-9 2017
Annual Return MGT-9 2018
Annual Return MGT-9 2019
Annual Return MGT-9 2020
Annual Return MGT-9 2021
Annual Return MGT-9 2022


Annual Secretarial Compliance Report

Reg 24A for BSE for year ending 31-03-2023
Reg 24A for BSE



Notice of Board Meetings
Notice of BM dt 09-02-2024
BM on 10-11-2023 1
Notice of BM dt 29-08-23
Notice dt 11-08-2023
Notice dt 01-02-2023
Notice dt 03-01-2019
Notice dt 13-07-2019
Notice dt 14-10-2019
Notice dt 10-06-2019
Notice dt 27-04-2019
Notice dt 04-03-2020
Notice dt 08-06-2020
Notice dt 13-07-2020
Notice dt 08-10-2020
Notice dt 09-01-2020
Notice dt 24-12-2020
Notice dt 24-12-2020_1
Notice dt 14-07-2021
Notice dt 13-01-2021
Notice dt 10-05-2021
Notice dt 03-11-2022
Notice dt 01-08-2022
Notice dt 16-01-2022
Notice dt 22-04-2022
Notice dt 11-09-2020
Notice dt 12-10-2021
Notice dt 01-02-2023



Kilpest Annual report 2022

Appointment Reappointment in AGM dt 22-09-2022
Investor Presenation 22-09-22
outcome of AGM 22-09-22
Proceedings of 50th AGM dt 22-09-2022
Notice of BM dt 14-02-2023
Draft letter of appointment ID
Secretarial Compliance Report for the year ended 31st March,2022
Notice of BM dt 12-11-2022
Newspaper Publication regarding AGM notice, Book Closure and E-voting
Newspaper publication of intimation of 50th AGM
Killpest Annual report 2021-22
Applicable-Tax-Deduction-at-Source-(TDS)-provisions-under-the-Income
Checklist_for_Receipt_of_Remittance-Foreign_Party
corporate declaration
Joint-Shareholders-declaration
KILPEST-DECLARATION-UNDER-RULE-37BC >
KILPEST-FORM-10F
KILPEST-FORM-15G
KILPEST-FORM-15H
KILPEST-NON-RESIDENT-TAX-DECLARATION
KILPEST-RESIDENT-TAX-DECLARATION
Self-Declaration-for-availment-of-Treaty-Benefit
Committee kilpest
Familiarization programme for Independent Directors
Form_MGT_7 Annual Return 2021

Financial Results 2023-2024

FR 30-06-2023
FR 30-09-2023 fr BSE Final

Financial Results 2022-2023

FR 31-03-2023

Financial Results 2021-2022

FR 31-12-2022
FR 30-09-2022
FR 30-06-2022
BM on 10-08-2022
Disclosure under Reg 23(9) of SEBI (LODR) Regulations 2015
FR 31-03-2022
Voting Result 2021
Unaudited Financial results for the quarter ended 31-12-2021
Unaudited Financial results for the quarter ended 30-09-2021
Scrutinizer's Report 2021
Outcome of AGM 2021
Investor's Presentation February 2022
Investor Presentation November 2021
Investor Presentation July 2021
Investor Presentation July 2019
Financial Results 31-12-2021

KYC Physical Shareholders

SEBI circular dt 17-11-23 for processing investor’s service requests and norms for furnishing PAN, KYC,Nomination
SEBI_circular for-Extension-of-timelines-in-eligible-demat-accounts
form-ISR-3 declaration-form-opting-out-nomination
form-ISR-2-confirmation-of-signature-of-securities-holder-by-bank
form-ISR-1-register-update-PAN-&-KYC-details
sebi-circular–norms-furnishing-pan-kyc-details-nomination
Form No. SH-14 Cancellation or Variation of Nomination
Form No. SH-13 Nomination form
Form-ISR-5 Transmission Request Form
Form-ISR-4 Request for Issue of Duplicate Certificate and other Service

Kilpest Amalgamation

Annexure V
Annexure VI
Annexure VIII
Annexure X
Annexure XI
Annexure XV
Audit committee Report
BR kilpest n 3B_
covering
CTC BR for scheme approval_3B BlackBio dt 27-12-2021
POST Amalgamation_B BLACKBIO_Clause31Q (1)
POST Amalgamation_KILPEST_Clause31Q
PRE Amalgamation_B BLACKBIO_Clause31Q (1)
PRE Amalgamation_KILPEST_Clause31Q
Pre n Post networth certificate
Processing fees details 2
Processing fees details
undertaking
3B AnnuaL Report 19-20
Annexure II
Annexure IV kilpest n 3B
Annexure IX
Annual Report KILPEST-2020
Annexure III
NCLT order dt 04-08-2023
NCLT order dt 13-07-2023
NCLT order dt 06-07-2023
NCLT order dt 23-06-2023
NCLT Order dt 04-05-2023
NCLT Order dt 09-03-2023
NCLT Order dt 11-08-2022
NCLT Order dt 12-05-2022
NCLT Order dt 24-11-2022
NCLT Order dt 25-08-2022
NCLT Order dt 31-03-2023
NCLT order dt 12-01-2023
Scheme of Amalgamation
Audited 3B BlackBio Audited BS 2022
Audited Kilpest Audited BS 2022
Auditors certificate for accounting treatment
NCLT Order dt 10-06-2022
NCLT order dt 15-09-2022
Observation Letter BSE dt 03-02-2022
NCLT Shareholder meeting outcome for BSE
NCLT Unsecured Creditors meeting outcome for BSE
NCLT Convenced Meeting-Notice for Unsecured Creditors
Abridged Prospectus
NCLT Convenced Meeting-Notice for Equity Shareholders
Complaint report
ANNEXURE III complaint report
Annexure IV FInancial summary
Audited Financials of 3B BlakcBio 30-09-2021
clarification certificate for 3B black bio PL
Compliance report Annexure IV
CTC BR for scheme approval_3B BlackBio dt 27-12-2021
CTC BR for scheme approval_KIL dt 27-12-2021
Fairness Opinion dt 27-12-2021
Independent Directors report of kilpest
latest financials Kilpest 30.09.2021
Latest Valuation Report
POST Amalgamation_B BLACKBIO_Clause31Q
POST Amalgamation_KILPEST_Clause31Q
PRE Amalgamation_KILPEST_Clause31Q
Pricing Certificate
Report of Audit committee meeting dt 27-12-2021
Revised PL 3B black bio 30.09.2021
undertaking for no change in exchange ratio
Valuation Workings
Valuation Workings

Directors Kilpest
Kilpest Code of conduct
EGM (16-02-2021)
Investor Presentation
Paper add for IEPF
List of shareholders whose dividend remains unclaimed and unpaid FY 16-17
List of shareholders whose shares are liable to be transferred to IEPF

Financial Results 2020-2021

Unaudited Financial Results for the quarter ended 30-06-2020
Unaudited Financial Results for the quarter ended 30-09-2020
Unaudited Financial Results for the quarter ended 31-12-2020
Investor Presentation June 2020
Investor Presentation July 2020
Investor Presentation November 2020
Investor Presentation February 2021
Annual Report KILPEST 2020
Outcome of AGM 2020

Financial Results 2019-2020

Voting Result 2019
Scrutinizer's Report 2019
Outcome of AGM 2019
Kilpest Annual Report 2019
Investor Presentation February 2020
Investor Presentation May 2019
Investor Presentation November 2019
Audited Financial results for the year ended 31-03-2020
Unaudited Financial results for the quarter ended 30-12-2019
Unaudited Financial results for the quarter ended 30-09-2019
Unaudited Financial results for the quarter ended 30-06-2019

Financial Results 2018-19

Scrutinizer's Report
Outcome of AGM 2018
Annual Report Kilpest 2018
Investor Presentation May 2019
Unaudited financial results for the year ended 31-03-2019
Voting Result 2018
Investor Presentation January 2019
Investor Presentation August 2018
Investor Presentation November 2018
Unaudited financial results for the quarter ended 30-09-2018
Unaudited financial results for the quarter ended 31-12-2018
Unaudited financial results for the quarter ended 30-06-2018

Financial Results 2017-18

1.Audited Results for the Quarter Year ended 31st March 2018
2.Unaudited Financial Results for quarter ended 31st December 2017
3.Unaudited FR QY ended 30th September 2017
4.Unaudited FR QY ended 30th June 2017
5 Investor Presentation  July 2017
6.Investor Presentation  Nov 2017
7.Investor Presentation  Feb 2018
8.Investor Presentation  May 2018
9.Annual report  2018
10.Outcome of AGM 2018
11.Scrutinizer report 2018
12  voting results 2018  

Financial Results 2016-17

• Audited Results for the QuarterYear ended 31st March 2017
• Unaudited Financial Results for quarter ended 31st December 2016
• Unaudited FR QY ended 30th September 2016
• Unaudited FR QY ended 30th June 2016
• Investor Presentation Jan 2017
• Investor Presentation May 2017
• Annual report 2017
• Outcome of AGM 2017v
• Scrutinizer report 2017 pdf
• Voting results 2017



Annual Report 2018
Financial Results for the quarter/year ended March 31,2018
Share Holder's Information
Notice of Board Meeting
EGM Notice : 18/12/2017
Voting Result EGM 18/12/2017
Code of Practices and procedures for Fair Disclosure of Unpublished Price Sensitive Information(pdf)
INTERIM LIST- Unpaid and Unclaimed as on 30-09-2016

Policy

Related party Transactions Policy
Terms and conditions of appointment of Independent Director
Archival Policy
KILPEST POLICY on materiality of events
KILPEST POLICY-ON-PRESERVATION-OF-DOCUMENTS
Risk Management Policy
Whistle Blower Policy
CSR policy KILPEST
Policy for determining material subsidiary

BSE

Financial Results on BSE
Corporate Announcements on BSE
Shareholding Pattern
Corporate Governance Report
Statutory Fillings with Stock Exchanges